INmune Bio, Inc. Financial Ratios — INMB Stock

Profitability (USD)

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-8.82	-69.54	-36.71	-37.16	-43.16	-30.04	-43.24	-87.16	-127.75
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	- -	- -	100	100	100	100	100	100
EBITDA Margin (%)	- -	- -	- -	- -	-111,163.64	-16,106.63	-6,938.77	-19,187.74	-304,535.71	-61,570
Operating Margin (%)	- -	- -	- -	- -	-111,163.64	-16,106.63	-6,938.77	-19,187.74	-304,535.71	-61,738
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	- -	- -	- -	- -	-109,990.91	-16,762.43	-7,299.2	-19,360	-300,585.71	-91,866
Profit Margin (%)	- -	- -	- -	- -	-109,990.91	-16,762.43	-7,299.2	-19,360	-300,585.71	-91,866
Net Income to Common Margin (%)	- -	- -	- -	- -	-109,990.91	-16,762.43	-7,299.2	-19,360	-300,585.71	-91,866
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API ChatGPT

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	- -	- -	- -	15	15	10	- -	1
ST Debt	- -	- -	- -	- -	- -	- -	5	10	- -	1
LT Debt	- -	- -	- -	- -	- -	15	10	- -	- -	- -
Total Debt/EBITDA	-1.54	- -	- -	-0.02	-0.01	-0.52	-0.59	-0.35	-0.01	-0.03
Net Debt/EBITDA	-0.92	1.4	0.01	0.75	1.8	2.07	1.44	0.87	0.49	0.8
Total Debt/EBIT	-1.54	- -	- -	-0.02	-0.01	-0.52	-0.59	-0.35	-0.01	-0.03
Net Debt/EBIT	-0.92	1.4	0.01	0.75	1.8	2.07	1.44	0.87	0.49	0.8
EBITDA to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBIT to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	-71.14	-6.24	-78.26	-86.9	-82.06	-63.73	-111.25	-210.88	-412.22	-646.07
Long-Term Debt/Equity (%)	- -	- -	- -	0.68	0.33	18.9	17.01	1.04	0.76	1.75
Long-Term Debt/Capital (%)	- -	- -	- -	-0.76	-0.38	-31.29	-13.51	-0.36	-0.15	-0.2
Long-Term Debt/Total Assets (%)	- -	- -	- -	0.65	0.31	15.17	12.5	0.7	0.62	1.27
Total Debt/Equity (%)	-234.58	- -	- -	0.71	0.41	18.99	25.47	27.37	1.2	4.4
Total Debt/Capital (%)	1,219.17	- -	- -	-0.8	-0.48	-31.43	-20.23	-9.51	-0.24	-0.5
Total Debt/Total Assets (%)	77.5	- -	- -	0.69	0.39	15.24	18.72	18.31	0.97	3.2
Net Debt to Equity	-139.64	-7.57	-1.13	-29.63	-56.68	-75.23	-62.32	-67.98	-65.18	-105.22
Net Debt/Capital (%)	-184.45	54.39	1.35	24.9	39.82	48.96	29.3	17.81	11.39	10.64
EBITDA	- -	-1	-12	-9	-12	-29	-26	-30	-43	-31
EBITDA-CapEx	- -	-1	-12	-9	-12	-44	-26	-30	-43	-32
Operating Income (Loss)	- -	-1	-12	-9	-12	-29	-26	-30	-43	-31

Liquidity (USD)

API ChatGPT

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	0.24	4.43	0.23	9.99	12.37	17.16	4.78	1.94	2.9	2.94
Current Ratio	0.75	6.13	1.03	11.09	13.51	18.95	5.92	2.16	3.14	3.55
Quick Ratio	0.67	5.48	1.01	10.91	13.38	18.42	5.55	2.07	3.09	3.48
CFO/Avg Current Liab	- -	-1.67	-3.63	-7.07	-7.22	-9.29	-2.97	-0.82	-2.6	-2.89
Common Equity/Total Assets	-71.14	-6.24	-78.26	-86.9	-82.06	-63.73	-111.25	-210.88	-412.22	-646.07
Long-Term Debt/Equity (%)	- -	- -	- -	0.68	0.33	18.9	17.01	1.04	0.76	1.75
Long-Term Debt/Capital (%)	- -	- -	- -	-0.76	-0.38	-31.29	-13.51	-0.36	-0.15	-0.2
Long-Term Debt/Total Assets (%)	- -	- -	- -	0.65	0.31	15.17	12.5	0.7	0.62	1.27
Total Debt/Equity (%)	-234.58	- -	- -	0.71	0.41	18.99	25.47	27.37	1.2	4.4
Total Debt/Capital (%)	1,219.17	- -	- -	-0.8	-0.48	-31.43	-20.23	-9.51	-0.24	-0.5
Total Debt/Total Assets (%)	77.5	- -	- -	0.69	0.39	15.24	18.72	18.31	0.97	3.2
CFO/Total Liabilities	-52.83	-245.98	-249.95	-625.73	-470.19	-144.54	-104.59	-63.51	-446.9	-255.83
CFO/CapEx	- -	-7.62	- -	- -	- -	-1.9	- -	- -	- -	-21.67
Altman's Z-Score	-3.07	-1.55	-70.71	35.01	62.62	3.91	0.87	0.47	-7.72	-8.77

Working Capital (USD)

API ChatGPT

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	- -	60	206	165	114	202	93	39
- Cash & Cash Equivalents	- -	1	- -	7	22	75	52	36	21	25
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -	15	15	10	- -	1
Enterprise Value	- -	-1	- -	53	185	105	77	177	73	15
Total Capital	- -	-1	-14	-21	-33	-48	-76	-110	-163	-208
Total Debt/Capital (%)	1,219.17	- -	- -	-0.8	-0.48	-31.43	-20.23	-9.51	-0.24	-0.5
Total Debt / EV	1.68	- -	- -	- -	- -	0.15	0.2	0.06	0.01	0.07
EV/Sales	- -	- -	- -	- -	16,784.98	579.86	205.39	1,142.28	5,185.85	298.1
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	- -	60	206	165	114	202	93	39
Diluted Enterprise Value	- -	-1	- -	53	185	105	77	177	73	15
EV per Share	0.02	- -	- -	5.14	15.4	6.51	4.28	9.85	3.64	0.6
TTM Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
TTM EBITDA	- -	-1	-12	-9	-12	-29	-26	-30	-43	-31
TTM Operating Income	- -	-1	-12	-9	-12	-29	-26	-30	-43	-31
TTM Cash Flow to Firm	- -	-1	-2	-5	-9	-29	-23	-12	-33	-23
TTM Free Cash Flow to Firm	- -	-1	-2	-5	-9	-14	-23	-12	-33	-22

Multiples (USD)

API ChatGPT

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	- -	-11.07	-23.08	-12.18	-5.01	-16.9	-2.79	-1.79
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	- -	-1	- -	53	185	105	77	177	73	15
Low Price	- -	- -	- -	3.5	2.2	9.23	4.63	5.87	4.32	1.38
EV/Sales	- -	- -	- -	- -	16,784.98	579.86	205.39	1,142.28	5,185.85	298.1
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	- -	-10.02	-7.25	-8.71	-5.3	-4.91	-4.04	-2.57
Price/Earnings High	- -	- -	- -	-15.39	-24.2	-16.15	-7.73	-7.06	-6.99	-6.27
Price/Earnings Low	- -	- -	- -	-4.69	-2.18	-4.91	-3.04	-3.52	-2.05	-0.74
Price/Book Value	- -	- -	- -	-2.8	-6.19	-2.58	-1.25	-1.68	-0.57	-0.18
Price/Book Value Average	- -	- -	- -	-3.62	-2.63	-4.15	-1.59	-1.23	-1.04	-0.56
Price/Book Value High	- -	- -	- -	-5.56	-8.78	-7.69	-2.32	-1.76	-1.8	-1.38
Price/Book Value Low	- -	- -	- -	-1.69	-0.79	-2.34	-0.91	-0.88	-0.53	-0.16
Price/Tangible Book Value	- -	- -	- -	8.4	9.28	2.58	2.61	9.36	5.98	1.64
Price/Tangible Book Value Average	- -	- -	- -	10.84	3.94	4.15	3.32	6.81	10.9	5.02
Price/Tangible Book Value High	- -	- -	- -	16.65	13.16	7.69	4.84	9.79	18.87	12.25
Price/Tangible Book Value Low	- -	- -	- -	5.07	1.19	2.34	1.9	4.88	5.53	1.45
Price/Sales	- -	- -	- -	- -	18,767.44	909.01	303.9	1,306.22	6,652.85	772.44
Price/Sales Average	- -	- -	- -	- -	7,973.78	1,460.72	387.14	950.22	12,135.33	2,361.18
Price/Sales High	- -	- -	- -	- -	26,614.45	2,706.54	564.52	1,366.54	20,998.5	5,763.56
Price/Sales Low	- -	- -	- -	- -	2,397.7	822.57	221.88	680.95	6,154.24	683.31
Price/Cash Flow	- -	- -	- -	-11.07	-23.08	-5.77	-5.01	-16.9	-2.79	-1.71
Price/Cash Flow Average	- -	- -	- -	-14.28	-9.81	-9.28	-6.38	-12.29	-5.09	-5.23
Price/Cash Flow High	- -	- -	- -	-21.94	-32.74	-17.19	-9.31	-17.68	-8.81	-12.76
Price/Cash Flow Low	- -	- -	- -	-6.69	-2.95	-5.22	-3.66	-8.81	-2.58	-1.51
Price/Free Cash Flow Average	- -	- -	- -	-14.28	-9.81	-19.58	-6.38	-12.29	-5.09	-5.48
Price/Free Cash Flow High	- -	- -	- -	-21.94	-32.74	-36.28	-9.31	-17.68	-8.81	-13.38
Price/Free Cash Flow Low	- -	- -	- -	-6.69	-2.95	-11.03	-3.66	-8.81	-2.58	-1.59
EV/Sales Average	- -	- -	- -	- -	5,991.33	1,131.57	288.63	786.28	10,668.33	1,886.84
EV/Sales High	- -	- -	- -	- -	24,632	2,377.39	466.01	1,202.6	19,531.5	5,289.22
EV/Sales Low	- -	- -	- -	- -	415.24	493.42	123.37	517.01	4,687.24	208.97
EV/EBITDA Average	-0.92	1.4	0.01	-7.54	-5.39	-7.03	-4.16	-4.1	-3.5	-3.06
EV/EBITDA High	-0.92	1.4	0.01	-11.97	-22.16	-14.76	-6.72	-6.27	-6.41	-8.59
EV/EBITDA Low	-0.92	1.4	0.01	-3.14	-0.37	-3.06	-1.78	-2.69	-1.54	-0.34
EV/EBIT Average	-0.92	1.4	0.01	-7.54	-5.39	-7.03	-4.16	-4.1	-3.5	-3.06
EV/EBIT High	-0.92	1.4	0.01	-11.97	-22.16	-14.76	-6.72	-6.27	-6.41	-8.57
EV/EBIT Low	-0.92	1.4	0.01	-3.14	-0.37	-3.06	-1.78	-2.69	-1.54	-0.34
Last Price	- -	- -	- -	5.8	17.22	10.2	6.34	11.26	4.67	1.56
High Price	- -	- -	- -	11.5	24.42	30.37	11.78	11.78	14.74	11.64
Enterprise Value Average	- -	-1	- -	70	66	205	108	122	149	94
Enterprise Value High	- -	-1	- -	111	271	430	174	186	273	264
Enterprise Value Low	- -	-1	- -	29	5	89	46	80	66	10

Shares Outstanding	11	11	11	11	13	18	18	18	22	27
Diluted Weighted Avg Shares	11	11	11	10	12	16	18	18	20	25
Basic Weighted Avg Shares	11	11	11	10	12	16	18	18	20	25
Revenue per Share	- -	- -	- -	- -	- -	0.01	0.02	0.01	- -	- -
EBITDA per Share	-0.02	-0.09	-1.11	-0.91	-1.02	-1.81	-1.45	-1.65	-2.14	-1.24
Operating Income per Share	-0.02	-0.09	-1.11	-0.91	-1.02	-1.81	-1.45	-1.65	-2.14	-1.25
Basic EPS, GAAP	-0.02	-0.07	-1.11	-0.75	-1.01	-1.88	-1.52	-1.67	-2.11	-1.86
Basic EPS from Cont Ops	-0.02	-0.07	-1.11	-0.75	-1.01	-1.88	-1.52	-1.67	-2.11	-1.86
Diluted EPS, GAAP	-0.02	-0.07	-1.11	-0.75	-1.01	-1.88	-1.52	-1.67	-2.11	-1.86
Diluted EPS from Cont Ops	-0.02	-0.07	-1.11	-0.75	-1.01	-1.88	-1.52	-1.67	-2.11	-1.86
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.03	-0.07	-0.18	-0.52	-0.75	-1.77	-1.27	-0.67	-1.67	-0.91
Free Cash Flow per Basic Share	-0.03	-0.08	-0.18	-0.52	-0.75	-2.7	-1.27	-0.67	-1.67	-0.95
Cash & Equivalents per Share	0.01	0.12	0.02	0.68	1.83	4.64	2.91	1.99	1.05	1
Book Value per Share	-0.03	-0.1	-1.21	-2.07	-2.78	-3.95	-5.08	-6.69	-8.18	-8.44
Tangible Book Value per Share	-0.01	0.14	- -	0.69	1.86	3.95	2.43	1.2	0.78	0.95

INmune Bio, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)